Association between oxidative stress and outcome in different subtypes of acute ischemic stroke

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tsai, Nai Wen ^a   Chang, Ya Ting ^a,b   Huang, Chi Ren ^a   Lin, Yu Jun ^a,b   Lin, Wei Che ^a   Cheng, Ben Chung ^a,b   Su, Chih Min ^a,b   Chiang, Yi Fang ^a   Chen, Shu Fang ^a   Huang, Chih Cheng ^a   Chang, Wen Neng ^a   Lu, Cheng Hsien ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; DANAPAROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; THIOL DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; FEMALE; HUMAN; HYPERLIPIDEMIA; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREDICTIVE VALUE; PROSPECTIVE STUDY; SERUM; STROKE PATIENT; ADOLESCENT; BLOOD; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGY; METABOLISM; PREVALENCE; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STROKE; TAIWAN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE; SULFHYDRYL COMPOUNDS; TAIWAN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; YOUNG ADULT;

EID: 84901794680     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/256879     Document Type: Article

References (33)

1. Suwanwela N., Koroshetz W. J., Acute ischemic stroke: overview of recent therapeutic developments. Annual Review of Medicine 2007 58 89 106 2-s2.0-34047103073 10.1146/annurev.med.58.070605.115306 (Pubitemid 46706503)
2. Samson Y., Lapergue B., Hosseini H., Inflammation and ischaemic stroke: current status and future perspectives. Revue Neurologique 2005 161 12 1177 1182 2-s2.0-30944436675 (Pubitemid 43116619)
3. Cherubini A., Ruggiero C., Polidori M. C., Mecocci P., Potential markers of oxidative stress in stroke. Free Radical Biology and Medicine 2005 39 7 841 852 2-s2.0-29144435788 10.1016/j.freeradbiomed.2005.06.025
4. Goodman T., Sharma P., Ferro A., The genetics of aspirin resistance. International Journal of Clinical Practice 2007 61 5 826 834 2-s2.0-34247177895 10.1111/j.1742-1241.2007.01344.x (Pubitemid 46587879)
5. Álvaro-González L. C., Freijo-Guerrero M. M., Sádaba-Garay F., Inflammatory mechanisms, arteriosclerosis and ischemic stroke: clinical data and perspectives. Revista de Neurologia 2002 35 5 452 462 2-s2.0-0036771289 (Pubitemid 36262146)
6. Chamorro A., Role of inflammation in stroke and atherothrombosis. Cerebrovascular Diseases 2004 17 3, supplement 1 5 2-s2.0-1642455873 10.1159/000075297 (Pubitemid 38134840)
7. Guzik T. J., Korbut R., Adamek-Guzik T., Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology 2003 54 4 469 487 2-s2.0-0347993913 (Pubitemid 38029745)
8. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J., NMDA-dependent superoxide production and neurotoxicity. Nature 1993 364 6437 535 537 2-s2.0-0027221998 10.1038/364535a0 (Pubitemid 23273099)
9. Piantadosi C. A., Zhang J., Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 1996 27 2 327 332 2-s2.0-0030060186 (Pubitemid 26045253)
10. Lipton S. A., Rosenberg P. A., Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders. New England Journal of Medicine 1994 330 9 613 622 2-s2.0-0028762647 10.1056/NEJM199403033300907 (Pubitemid 24065797)
11. Walder C. E., Green S. P., Darbonne W. C., Mathias J., Rae J., Dinauer M. C., Curnutte J. T., Thomas G. R., Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 1997 28 11 2252 2258 2-s2.0-0030663253 (Pubitemid 27497931)
12. Matsuo Y., Kihara T., Ikeda M., Ninomiya M., Onodera H., Kogure K., Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. Journal of Cerebral Blood Flow and Metabolism 1995 15 6 941 947 2-s2.0-0028847050
13. Sies H., Oxidative stress: oxidants and antioxidants. Experimental Physiology 1997 82 2 291 295 2-s2.0-0030894162 (Pubitemid 27182306)
14. Karatas F., Karatepe M., Baysar A., Determination of free malondialdehyde in human serum by high-performance liquid chroma tography. Analytical Biochemistry 2002 311 1 76 79 2-s2.0-0036901664 10.1016/S0003-2697(02)00387-1 (Pubitemid 35463490)
15. Gariballa S. E., Hutchin T. P., Sinclair A. J., Antioxidant capacity after acute ischaemic stroke. QJM 2002 95 10 685 690 2-s2.0-0036797076 (Pubitemid 35203637)
16. Spranger M., Krempien S., Schwab S., Donneberg S., Hacke W., Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury: correlation with clinical course and infarct size. Stroke 1997 28 12 2425 2428 2-s2.0-0031439424 (Pubitemid 28007644)
17. Chang C.-Y., Lai Y.-C., Cheng T.-J., Lau M.-T., Hu M.-L., Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radical Research 1998 28 1 15 24 (Pubitemid 28163810)
18. Leppälä J. M., Virtamo J., Fogelholm R., Albanes D., Heinonen O. P., Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 1999 30 12 2535 2540 2-s2.0-0345533860
19. Adams H. P. Jr., Bendixen B. H., Kappelle L. J., Biller J., Love B. B., Gordon D. L., Marsh E. E. III, Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993 24 1 35 41 2-s2.0-0027514354 (Pubitemid 23014379)
20. Sacco R. L., Adams R., Albers G., Alberts M. J., Benavente O., Furie K., Goldstein L. B., Gorelick P., Halperin J., Harbaugh R., Johnston S. C., Katzan I., Kelly-Hayes M., Kenton E. J., Marks M., Schwamm L. H., Tomsick T., Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association council on stroke-co-sponsored by the council on cardiovascular radiology and intervention. The American Academy of Neurology affirms the value of this guideline. Stroke 2006 37 2 577 617 2-s2.0-33644867063 10.1161/01.STR.0000199147.30016.74
21. Sulter G., Steen C., De Keyser J., Use of the Barthel Index and Modified Rankin Scale in acute stroke trials. Stroke 1999 30 8 1538 1541 2-s2.0-0032796473 (Pubitemid 29379599)
22. Huang T.-L., Liou C.-W., Lin T.-K., Serum thiobarbituric acid-reactive substances and free thiol levels in schizophrenia patients: effects of antipsychotic drugs. Psychiatry Research 2010 177 1-2 18 21 2-s2.0-77952430708 10.1016/j.psychres.2009.01.017
23. Demirkaya S., Topcuoglu M. A., Aydin A., Ulas U. H., Isimer A. I., Vural O., Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. European Journal of Neurology 2001 8 1 43 51 2-s2.0-0035122243 10.1046/j.1468-1331.2001. 00166.x (Pubitemid 32154573)
24. Sharpe P. C., Mulholland C., Trinick T., Ascorbate and malondialdehyde in stroke patients. Irish Journal of Medical Science 1994 163 11 488 491 2-s2.0-0028061807 (Pubitemid 24343177)
25. Polidori M. C., Cherubini A., Stahl W., Senin U., Sies H., Mecocci P., Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radical Research 2002 36 3 265 268 2-s2.0-0036521850 10.1080/10715760290019273 (Pubitemid 35154069)
26. Lammie G. A., Brannan F., Slattery J., Warlow C., Nonhypertensive cerebral small-vessel disease: an autopsy study. Stroke 1997 28 11 2222 2229 2-s2.0-0030663431 (Pubitemid 27497927)
27. Rothwell P. M., Atherothrombosis and ischaemic stroke. British Medical Journal 2007 334 7590 379 380 2-s2.0-33847751889 10.1136/bmj.38964.489051.80 (Pubitemid 46374635)
28. Tsai N. W., Lee L. H., Huang C. R., Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome. Critical Care 2014 18 1, article R16
29. de Keyser J., de Klippel N., Merkx H., Vervaeck M., Herroelen L., Serum concentrations of vitamins A and E and early outcome after ischaemic stroke. The Lancet 1992 339 8809 1562 1565 2-s2.0-0026643152 10.1016/0140-6736(92)91830-2
30. Leinonen J. S., Ahonen J.-P., Lönnrot K., Jehkonen M., Dastidar P., Molnár G., Alho H., Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000 31 1 33 39 2-s2.0-0033963330 (Pubitemid 30035749)
31. Idicula T. T., Brogger J., Naess H., Waje-Andreassen U., Thomassen L., Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. BMC Neurology 2009 9, article 18 2-s2.0-65649149373 10.1186/1471-2377-9-18
32. Elkind M. S. V., Cheng J., Rundek T., Boden-Albala B., Sacco R. L., Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. Journal of Stroke and Cerebrovascular Diseases 2004 13 5 220 227 2-s2.0-7044223228 10.1016/j.jstrokecerebrovasdis.2004.07.004 (Pubitemid 39421631)
33. Tsai N. W., Lee L. H., Huang C. R., The association of statin therapy and high-sensitivity C-reactive protein level for predicting clinical outcome in acute non-cardio-embolic ischemic stroke. Clinica Chimica Acta 2012 413 23-24 1861 1865